Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Mozobil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Venus Remedies receives Saudi FDA approval for Plerixafor
    Venus Remedies receives Saudi FDA approval for Plerixafor

    22 May 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/venus-remedies-receives-saudi-fda-approval-for-plerixafor/

    EXPRESSPHARMA
    22 May 2026
    Share Share
    Ayrmid Reports New Motixafortide Data on Stem Cell Mobilization
    Ayrmid Reports New Motixafortide Data on Stem Cell Mobilization

    04 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-04/ayrmid-reports-additional-new-real-world-data-on-motixafortide-for-stem-cell-mobilization-in-sickle

    PHARMIWEB
    04 Feb 2026
    Share Share
    Ayrmid Unveils Motixafortide Data For Stem Cell Mobilization
    Ayrmid Unveils Motixafortide Data For Stem Cell Mobilization

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/ayrmid-presents-new-data-on-motixafortide-for-stem-cell-mobilization-in-sickle-cell-disease

    PHARMIWEB
    08 Dec 2025
    Share Share
    Ayrmid Reports Promising New Real-World Data on Motixafortide
    Ayrmid Reports Promising New Real-World Data on Motixafortide

    06 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-06/ayrmid-reports-promising-new-real-world-data-on-motixafortide-for-stem-cell-mobilization-in-sickle-c

    PHARMIWEB
    06 Dec 2025
    Share Share
    Gland Pharma's Generic Plerixafor Receives Approval in the U.S
    Gland Pharma's Generic Plerixafor Receives Approval in the U.S

    03 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206644

    FDA
    03 May 2024
    Share Share
    Fresenius Kabi Launches Plerixafor Injection
    Fresenius Kabi Launches Plerixafor Injection

    09 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230809432476/en

    BUSINESSWIRE
    09 Aug 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.